CAMBRIDGE, Mass., September 5, 2017 – Myomo, Inc. (NYSE MKT: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced that its Chairman and Chief Executive Officer, Paul R. Gudonis, and its Chief Financial Officer, Ralph Goldwasser, will present at the 19th Annual Rodman & Renshaw Global Investment Conference at the Lotte New York Palace Hotel in New York City. The presentation will take place at 10:00 A.M. EDT on Tuesday, September 12, 2017.
In addition, any investors attending the conference that wish to meet with Mr. Gudonis for a one-on-one meeting should contact Lily Khaykina at email@example.com.
Myomo, Inc. is a commercial stage medical robotics Company that offers expanded mobility for those suffering from neurological disorders and upper limb paralysis. Based on patented technology developed at MIT and the Company, Myomo develops and markets the MyoPro® product line of lightweight, non-invasive, powered arm braces to restore function in the paralyzed or weakened arms and hands of individuals that have suffered a stroke, spinal cord or nerve injury such as brachial plexus injury, or other neuromuscular disability such as amyotrophic lateral sclerosis (ALS) or multiple sclerosis (MS). It is provided through clinical relationships with VA medical centers, leading rehabilitation hospitals, and Orthotics and Prosthetics (“O&P”) practices. Several hundred have been successfully used by patients. It is the only device that, sensing a patient’s own neurological signals through non-invasive sensors on the arm, can restore their ability to use their arms and hands so that they can return to work, live independently and reduce their cost of care. Myomo is headquartered in Cambridge, Massachusetts, with sales and clinical professionals across the U.S. For more information, please visit www.myomo.com.